Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates
Jennifer L. Fisher, Elizabeth J. Wilk, Vishal H. Oza…·Brittany N. Lasseigne
The paper identifies drug repurposing candidates for low-survival cancers by prioritizing drugs that reverse disease-associated gene signatures using three methods.